What AI says about Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biotechnology company developing IL-1β-based treatments for immune-mediated inflammatory diseases. Its lead asset, abdakibart (AVTX-009), recently reported positive topline data from a Phase 2 trial in moderate to severe hidradenitis suppurativa.